Erythrocin Stearate

Product NDC: 10544-594
11-digit product format: 105440594
Labeler code: 10544
Product ID: 10544-594_3106c828-9c18-4530-89ae-b1c99ab6aa22
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Erythromycin Stearate
Dosage form: TABLET, FILM COATED
Route: ORAL
Labeler: Blenheim Pharmacal, Inc.
Application: ANDA060359
Marketing category: ANDA
Marketing start: 2010-03-09
Marketing end: 0000-00-00
Substance: ERYTHROMYCIN STEARATE
Active strength: 250 mg/1
Pharmacologic classes: Decreased Sebaceous Gland Activity [PE],Macrolide [EPC],Macrolide Antimicrobial [EPC],Macrolides [CS]
NDC exclude flag: E
Listing certified through: 2017-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 3 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	10544-594		I	Inactivated by FDA	2026-08-03
excluded package	package	10544-594	10544-594-28	I	Inactivated by FDA	2026-08-03
excluded package	package	10544-594	10544-594-40	I	Inactivated by FDA	2026-08-03

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 2 · 66 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	10544-594-40	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	10544-594-28	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	10544-594-40	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	10544-594-28	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	10544-594-40	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	10544-594-28	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	10544-594-40	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	10544-594-28	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	10544-594-40	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	10544-594-28	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	10544-594-40	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	10544-594-28	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	10544-594-40	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	10544-594-28	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	10544-594-40	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	10544-594-28	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	10544-594-40	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	10544-594-28	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	10544-594-40	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	10544-594-28	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	10544-594-40	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	10544-594-28	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	10544-594-40	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	10544-594-28	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded product	product		`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	10544-594-40	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	10544-594-28	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded product	product		`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	10544-594-40	`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	10544-594-28	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded product	product		`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	10544-594-40	`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	10544-594-28	`1332a3947898…`	`d4bfe170f9cd…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded product	product		`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded package	package	10544-594-40	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded package	package	10544-594-28	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded product	product		`86f5da6cb304…`	`a595104c45d7…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded package	package	10544-594-40	`86f5da6cb304…`	`a595104c45d7…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded package	package	10544-594-28	`86f5da6cb304…`	`a595104c45d7…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded product	product		`bd6a592717d7…`	`303034d00443…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded package	package	10544-594-40	`bd6a592717d7…`	`303034d00443…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded package	package	10544-594-28	`bd6a592717d7…`	`303034d00443…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded product	product		`8dfbde2a14a4…`	`c9ff85d89658…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded package	package	10544-594-40	`8dfbde2a14a4…`	`c9ff85d89658…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded package	package	10544-594-28	`8dfbde2a14a4…`	`c9ff85d89658…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded product	product		`e2bbac7714bc…`	`27bdfed8d636…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded package	package	10544-594-40	`e2bbac7714bc…`	`27bdfed8d636…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded package	package	10544-594-28	`e2bbac7714bc…`	`27bdfed8d636…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	RLD / RS
A060359-001	ERYTHROCIN STEARATE	ERYTHROMYCIN STEARATE	EQ 250MG BASE	TABLET / ORAL	Approved before 1982
A060359-002	ERYTHROCIN STEARATE	ERYTHROMYCIN STEARATE	EQ 125MG BASE	TABLET / ORAL	Approved before 1982
A060359-003	ERYTHROCIN STEARATE	ERYTHROMYCIN STEARATE	EQ 500MG BASE	TABLET / ORAL	Approved before 1982

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 4 · 123 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	RLD / RS	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A060359-001	ERYTHROCIN STEARATE	EQ 250MG BASE	TABLET / ORAL	Approved before 1982	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A060359-002	ERYTHROCIN STEARATE	EQ 125MG BASE	TABLET / ORAL	Approved before 1982	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A060359-003	ERYTHROCIN STEARATE	EQ 500MG BASE	TABLET / ORAL	Approved before 1982	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A060359-001	ERYTHROCIN STEARATE	EQ 250MG BASE	TABLET / ORAL	Approved before 1982	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A060359-002	ERYTHROCIN STEARATE	EQ 125MG BASE	TABLET / ORAL	Approved before 1982	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A060359-003	ERYTHROCIN STEARATE	EQ 500MG BASE	TABLET / ORAL	Approved before 1982	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A060359-001	ERYTHROCIN STEARATE	EQ 250MG BASE	TABLET / ORAL	Approved before 1982	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A060359-002	ERYTHROCIN STEARATE	EQ 125MG BASE	TABLET / ORAL	Approved before 1982	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A060359-003	ERYTHROCIN STEARATE	EQ 500MG BASE	TABLET / ORAL	Approved before 1982	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A060359-001	ERYTHROCIN STEARATE	EQ 250MG BASE	TABLET / ORAL	RS, Approved before 1982	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A060359-002	ERYTHROCIN STEARATE	EQ 125MG BASE	TABLET / ORAL	Approved before 1982	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A060359-003	ERYTHROCIN STEARATE	EQ 500MG BASE	TABLET / ORAL	Approved before 1982	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A060359-001	ERYTHROCIN STEARATE	EQ 250MG BASE	TABLET / ORAL	RS, Approved before 1982	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A060359-002	ERYTHROCIN STEARATE	EQ 125MG BASE	TABLET / ORAL	Approved before 1982	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A060359-003	ERYTHROCIN STEARATE	EQ 500MG BASE	TABLET / ORAL	Approved before 1982	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A060359-001	ERYTHROCIN STEARATE	EQ 250MG BASE	TABLET / ORAL	RS, Approved before 1982	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A060359-002	ERYTHROCIN STEARATE	EQ 125MG BASE	TABLET / ORAL	Approved before 1982	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A060359-003	ERYTHROCIN STEARATE	EQ 500MG BASE	TABLET / ORAL	Approved before 1982	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A060359-001	ERYTHROCIN STEARATE	EQ 250MG BASE	TABLET / ORAL	RS, Approved before 1982	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A060359-002	ERYTHROCIN STEARATE	EQ 125MG BASE	TABLET / ORAL	Approved before 1982	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A060359-003	ERYTHROCIN STEARATE	EQ 500MG BASE	TABLET / ORAL	Approved before 1982	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A060359-001	ERYTHROCIN STEARATE	EQ 250MG BASE	TABLET / ORAL	RS, Approved before 1982	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A060359-002	ERYTHROCIN STEARATE	EQ 125MG BASE	TABLET / ORAL	Approved before 1982	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A060359-003	ERYTHROCIN STEARATE	EQ 500MG BASE	TABLET / ORAL	Approved before 1982	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A060359-001	ERYTHROCIN STEARATE	EQ 250MG BASE	TABLET / ORAL	RS, Approved before 1982	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A060359-002	ERYTHROCIN STEARATE	EQ 125MG BASE	TABLET / ORAL	Approved before 1982	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A060359-003	ERYTHROCIN STEARATE	EQ 500MG BASE	TABLET / ORAL	Approved before 1982	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A060359-001	ERYTHROCIN STEARATE	EQ 250MG BASE	TABLET / ORAL	RS, Approved before 1982	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A060359-002	ERYTHROCIN STEARATE	EQ 125MG BASE	TABLET / ORAL	Approved before 1982	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A060359-003	ERYTHROCIN STEARATE	EQ 500MG BASE	TABLET / ORAL	Approved before 1982	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A060359-001	ERYTHROCIN STEARATE	EQ 250MG BASE	TABLET / ORAL	RS, Approved before 1982	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A060359-002	ERYTHROCIN STEARATE	EQ 125MG BASE	TABLET / ORAL	Approved before 1982	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A060359-003	ERYTHROCIN STEARATE	EQ 500MG BASE	TABLET / ORAL	Approved before 1982	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A060359-001	ERYTHROCIN STEARATE	EQ 250MG BASE	TABLET / ORAL	RS, Approved before 1982	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A060359-002	ERYTHROCIN STEARATE	EQ 125MG BASE	TABLET / ORAL	Approved before 1982	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A060359-003	ERYTHROCIN STEARATE	EQ 500MG BASE	TABLET / ORAL	Approved before 1982	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A060359-001	ERYTHROCIN STEARATE	EQ 250MG BASE	TABLET / ORAL	RS, Approved before 1982	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A060359-002	ERYTHROCIN STEARATE	EQ 125MG BASE	TABLET / ORAL	Approved before 1982	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A060359-003	ERYTHROCIN STEARATE	EQ 500MG BASE	TABLET / ORAL	Approved before 1982	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A060359-001	ERYTHROCIN STEARATE	EQ 250MG BASE	TABLET / ORAL	RS, Approved before 1982	`8072bd15b7f6…`

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
d329c2e1-5ae8-4e64-aea0-77ecea3fa1ab	Product name	3	20250717
3b331500-3b74-bd2b-fede-d46839f2f4d5	Product name	6	20240313
fdae2630-eae0-4769-abfd-8f33d5b771b4	Product name	3	20240202
8c898317-b543-1e4e-254f-84cec2f3f57e	Product name	2	20191002
64ae94c0-3212-d73a-92da-9e6dd85c6ebe	Product name	2	20180118
edcfa1cf-915f-1a4c-d0aa-508cc66e70d9	Product name	2	20170816
ad75fcfd-a339-42a1-9c60-43ba2c654cfa	Product name	1	20170810
d5e51f11-ad28-caa4-4b49-4143974782ad	Product name	1	20150831
57850177-5927-151f-e1fa-7e2ca47f81e5	Product name	1	20140508
8ee71591-1d8f-e24e-242b-bfef131e3168	Product name	1	20140508
bff5cf99-0f45-fa15-2a76-b160c3c4cc3c	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
10544-594-28	2020-01-31	C162847	48780-1	9d75b9d0-d105-f424-e053-dadaa90a57ce	ERYTHROCIN® STEARATE (erythromycin stearate tablets, USP) Filmtab® Tablets
10544-594-40	2020-01-31	C162847	48780-1	9d75b9d0-d105-f424-e053-dadaa90a57ce	ERYTHROCIN® STEARATE (erythromycin stearate tablets, USP) Filmtab® Tablets

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
10544-594-28	Erythrocin Stearate	28 in 1 BOTTLE	TABLET, FILM COATED	28		3
10544-594-40	Erythrocin Stearate	40 in 1 BOTTLE	TABLET, FILM COATED	40		3

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
10544-594-28	EA - Each	10544-594	a2c8c4a4-d503-4d43-8c8a-8c9026b3afe5	1	2015-10-02
10544-594-40	EA - Each	10544-594	4f776fc2-06ab-4871-a557-73b3c0027d67	1	2015-10-02

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
ERYTHROMYCIN STEARATE	ACTIVE INGREDIENT	LXW024X05M	ERYTHROCIN STEARATE (ERYTHROMYCIN STEARATE) TABLET, FILM COATED [BLENHEIM PHARMACAL, INC.]	3
ERYTHROMYCIN	ACTIVE MOIETY	63937KV33D	ERYTHROCIN STEARATE (ERYTHROMYCIN STEARATE) TABLET, FILM COATED [BLENHEIM PHARMACAL, INC.]	3
CARBOXYMETHYLCELLULOSE SODIUM	INACTIVE INGREDIENT	K679OBS311	ERYTHROCIN STEARATE (ERYTHROMYCIN STEARATE) TABLET, FILM COATED [BLENHEIM PHARMACAL, INC.]	3
D&C RED NO. 7	INACTIVE INGREDIENT	ECW0LZ41X8	ERYTHROCIN STEARATE (ERYTHROMYCIN STEARATE) TABLET, FILM COATED [BLENHEIM PHARMACAL, INC.]	3
FD&C RED NO. 3	INACTIVE INGREDIENT	PN2ZH5LOQY	ERYTHROCIN STEARATE (ERYTHROMYCIN STEARATE) TABLET, FILM COATED [BLENHEIM PHARMACAL, INC.]	3
MAGNESIUM HYDROXIDE	INACTIVE INGREDIENT	NBZ3QY004S	ERYTHROCIN STEARATE (ERYTHROMYCIN STEARATE) TABLET, FILM COATED [BLENHEIM PHARMACAL, INC.]	3
POLACRILIN POTASSIUM	INACTIVE INGREDIENT	0BZ5A00FQU	ERYTHROCIN STEARATE (ERYTHROMYCIN STEARATE) TABLET, FILM COATED [BLENHEIM PHARMACAL, INC.]	3
POLYETHYLENE GLYCOLS	INACTIVE INGREDIENT	3WJQ0SDW1A	ERYTHROCIN STEARATE (ERYTHROMYCIN STEARATE) TABLET, FILM COATED [BLENHEIM PHARMACAL, INC.]	3
POVIDONES	INACTIVE INGREDIENT	FZ989GH94E	ERYTHROCIN STEARATE (ERYTHROMYCIN STEARATE) TABLET, FILM COATED [BLENHEIM PHARMACAL, INC.]	3
PROPYLENE GLYCOL	INACTIVE INGREDIENT	6DC9Q167V3	ERYTHROCIN STEARATE (ERYTHROMYCIN STEARATE) TABLET, FILM COATED [BLENHEIM PHARMACAL, INC.]	3
SODIUM CITRATE	INACTIVE INGREDIENT	1Q73Q2JULR	ERYTHROCIN STEARATE (ERYTHROMYCIN STEARATE) TABLET, FILM COATED [BLENHEIM PHARMACAL, INC.]	3
SORBIC ACID	INACTIVE INGREDIENT	X045WJ989B	ERYTHROCIN STEARATE (ERYTHROMYCIN STEARATE) TABLET, FILM COATED [BLENHEIM PHARMACAL, INC.]	3
SORBITAN MONOOLEATE	INACTIVE INGREDIENT	06XEA2VD56	ERYTHROCIN STEARATE (ERYTHROMYCIN STEARATE) TABLET, FILM COATED [BLENHEIM PHARMACAL, INC.]	3
STARCH, CORN	INACTIVE INGREDIENT	O8232NY3SJ	ERYTHROCIN STEARATE (ERYTHROMYCIN STEARATE) TABLET, FILM COATED [BLENHEIM PHARMACAL, INC.]	3
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	ERYTHROCIN STEARATE (ERYTHROMYCIN STEARATE) TABLET, FILM COATED [BLENHEIM PHARMACAL, INC.]	3
VANILLIN	INACTIVE INGREDIENT	CHI530446X	ERYTHROCIN STEARATE (ERYTHROMYCIN STEARATE) TABLET, FILM COATED [BLENHEIM PHARMACAL, INC.]	3

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
10544-594	ERYTHROCIN STEARATE (ERYTHROMYCIN STEARATE) TABLET, FILM COATED [BLENHEIM PHARMACAL, INC.]	3	Legacy NDC, 2 package rows	20150801_8aa50166-8f4f-4389-8354-c558c20e63b6.zip

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
LXW024X05M	ERYTHROMYCIN STEARATE	643-22-1	ERYTHROMYCIN STEARATE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
750839	Erythrocin Stearate 250 MG Oral Tablet	PSN	8aa50166-8f4f-4389-8354-c558c20e63b6	3
750841	Erythrocin Stearate 500 MG Oral Tablet	PSN	8aa50166-8f4f-4389-8354-c558c20e63b6	3
686355	erythromycin stearate 250 MG Oral Tablet	PSN	8aa50166-8f4f-4389-8354-c558c20e63b6	3
686406	erythromycin stearate 500 MG Oral Tablet	PSN	8aa50166-8f4f-4389-8354-c558c20e63b6	3
750839	erythromycin stearate 250 MG Oral Tablet [Erythrocin Stearate]	SBD	8aa50166-8f4f-4389-8354-c558c20e63b6	3
750841	erythromycin stearate 500 MG Oral Tablet [Erythrocin Stearate]	SBD	8aa50166-8f4f-4389-8354-c558c20e63b6	3
686355	erythromycin stearate 250 MG Oral Tablet	SCD	8aa50166-8f4f-4389-8354-c558c20e63b6	3
686406	erythromycin stearate 500 MG Oral Tablet	SCD	8aa50166-8f4f-4389-8354-c558c20e63b6	3
750839	Erythrocin Stearate 250 MG Oral Tablet	SY	8aa50166-8f4f-4389-8354-c558c20e63b6	3
750841	Erythrocin Stearate 500 MG Oral Tablet	SY	8aa50166-8f4f-4389-8354-c558c20e63b6	3

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Status
10544-594-28	10544059428	28 in 1 BOTTLE	Historical
10544-594-40	10544059440	40 in 1 BOTTLE	Historical

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
ERYTHROCIN® STEARATE (erythromycin stearate tablets, USP) Filmtab® Tablets	Blenheim Pharmacal, Inc.	2015-07-31	HUMAN PRESCRIPTION DRUG LABEL	3